News > The Liver Meeting® 2017


The Liver Meeting® 2017


OWL is presenting new innovations in liver disease diagnosis at The Liver Meeting 2017 and we would like to invite you to visit OWL booth. Our team members will be on hand to discuss recent technical achievements.


Place and date: Walter E. Washington Convention Center, Washington DC. 20-24 October 2017.


OWL attendees: Pablo Ortiz, MD, PhD; Azucena Castro, PhD; Cristina Alonso, PhD; Rebeca Mayo PhD; Marta Iruarrizaga-Lejarreta, PhD; and Tim Montgomery.

Booth: #127




Oral presentation:

Application of human NASH-based transcriptome and metabolome profiles in preclinical models for the translational study of drug effect on liver fibrosis.

Presenting author: Martine C Morrison (TNO, the Netherlands).

Session: Parallel 39: Steatosis and steatohepatitis: Experimental II. Date: Monday, October 23, 4:45-5:00 PM.


Poster presentations:

Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis (PSC), cholangiocarcinoma (CCA) and hepatocellular carcinoma (HCC).

Poster #1616, displayed Sunday, October 22, from 8:00 AM to 5:30 PM.


Metabolomics approach addresses the heterogeneity of NAFLD and determines subtypes associated with different metabolic alterations.

Poster #2227, displayed Monday, October 23, from 8:00 AM to 5:30 PM.


The effect of Aramchol on fibrosis is mediated by elevation of glutathione, improvement of fatty acid oxidation and mantenance of redox homeostasis.

Poster #2060, displayed Monday, October 23, from 8:00 AM to 5:30 PM.


Reverse translation of clinical biomarkers into experimental models of NASH.

Poster #2071, displayed Monday, October 23, from 8:00 AM to 5:30 PM.



Visit us to know our newest findings!

OWL is a trading name of
Parque Tecnológico de Bizkaia
Edificio 502 - Planta 0
48160 Derio - Bizkaia - Spain
+34 94 431 85 40

With this web OWL intends to provide users with information to better understand their health and their diagnosed illnesses. You should consult with a
qualified physician for diagnosis and for answers to your personal questions/circunstances.
Last update: 11/29/2021

With the collaboration of: